Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Drug-coated stents effective in ’real world’ patients

23.12.2003


Drug-coated stents are safe and effective at preventing death, heart attack or repeat procedures in "real world" patients who are often sicker or older than those selected for clinical trials, according to a study in today’s rapid issue of Circulation: Journal of the American Heart Association.



The drug-coated stents were more effective than uncoated stents, just as they had been in clinical trials, said lead investigator Patrick W. Serruys, M.D., Ph.D., professor of cardiology at Erasmus Medical Center in Rotterdam, the Netherlands.

This "real world" research is important because patients in clinical trials of drug-coated stents "were a very select group, whereas this registry is an attempt to look at in an unselected population," Serruys said. "Sixty-eight percent of the patients in this study did not meet the selection criteria for the clinical trials."


Stents are tiny flexible wire mesh tubes that prop open blocked arteries in the heart. Drug-eluting stents are coated with slow-release drugs that help prevent cell re-growth that can re-narrow the artery.

These one-year results from the Rampamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry show that 9.7 percent of patients who received the drug-eluting stents had a major adverse cardiac event, compared with 14.8 percent of those treated with bare metal stents.

Only 3.7 percent of the patients treated with drug-eluting stents had a renarrowing of the treated vessel that required repeat procedures, while 10.9 percent of the patients in the bare-metal stent group required repeat interventions.

"The treatment effects – particularly the reduction of reinterventions – were similar across very different subgroups of patients," Serruys said. "The effect was the same in long lesions and short lesions, in small vessels, and in all kinds of anatomic settings."

The study included 508 patients with previously untreated blocked arteries who were treated with sirolimus-eluting Cypher stents. Four hundred fifty patients with similar blockages were treated with bare metal stents. About half of the patients admitted to both groups had acute coronary syndromes (heart attack or angina) and 16 percent in each group also had diabetes. Generally, patients selected for treatment with the coated stents were more likely to have multi-vessel disease, more complicated disease and required more stents than patients treated with uncoated stents.

"We have had basically two major steps in interventional cardiology," Serruys said. "The first was revascularization through percutaneous intervention with the angioplasty balloon in 1977 followed in 1986 by the introduction of the stent. The drug-eluting stent is the next major step."

In an accompanying editorial David P. Faxon, M.D., professor of medicine at the University of Chicago, wrote that the RESEARCH results "go a long way in reassuring the practitioner that drug-eluting stents are in fact safe and effective in a wide variety of patients undergoing ’real world’ angioplasty." The next step should be a mandatory registry established by the Food and Drug Administration to report problems, he said.

Faxon also addressed recent FDA public notifications that warned physicians of sub-acute thrombosis (blood clot) and hypersensitivity reactions linked to using the Cordis Cypher Coronary Stent. "Thus far, 290 cases of sub-acute stent thrombosis have been reported and more than 60 patients have died. But the thrombosis rate is about 1 percent, which is similar to the expected rate for bare metal stents."

###
Serruys’ co-authors are Pedro A. Lemos, M.D.; Ron T. van Domburg, Ph.D.; Francesco Saia, M.D.; Chourmouzios A. Arampatzis, M.D.; Angela Hoye, MB, ChB, MRCP; Muzaffer Degertekin, M.D.; Kengo Tanabe, M.D.; Joost Daemen; Tommy K.K. Liu, Eugene McFadden, M.B., ChB; Georgios Sianos, M.D., Ph.D.; Sjoerd H. Hofma, M.D.; Pieter C. Smits, M.D., Ph.D.; Willem J. van der Giessen, M.D., Ph.D.; and Pim de Feyter, M.D., Ph.D.

CONTACT: For journal copies only,
please call: 214-706-1396


For other information, call:
Carole Bullock: 214-706-1279
Bridgette McNeill: 214-706-1135
Julie Del Barto (broadcast): 214-706-1330

Carole Bullock | EurekAlert!
Further information:
http://www.americanheart.org/

More articles from Studies and Analyses:

nachricht Drone vs. truck deliveries: Which create less carbon pollution?
31.05.2017 | University of Washington

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Quantum thermometer or optical refrigerator?

23.06.2017 | Physics and Astronomy

A 100-year-old physics problem has been solved at EPFL

23.06.2017 | Physics and Astronomy

Equipping form with function

23.06.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>